Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Jun 4, 2009

34519_dirs_2009-06-04_1cd36f49-3671-4ef2-be03-11a54891bc3b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-06-02

Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-06-02 Common stock, par value $0.10 per share P 300 $1.81 Acquired 441002 Direct
2009-06-03 Common stock, par value $0.10 per share P 250 $1.99 Acquired 441252 Direct
2009-06-03 Common stock, par value $0.10 per share P 350 $2.04 Acquired 441602 Direct
2009-06-03 Common stock, par value $0.10 per share P 1150 $2.05 Acquired 442752 Direct
2009-06-03 Common stock, par value $0.10 per share P 800 $2.05 Acquired 443552 Direct
2009-06-04 Common stock, par value $0.10 per share P 300 $1.99 Acquired 443852 Direct
2009-06-04 Common stock, par value $0.10 per share P 300 $2.00 Acquired 444152 Direct
2009-06-04 Common stock, par value $0.10 per share P 500 $1.998 Acquired 444652 Direct
2009-06-04 Common stock, par value $0.10 per share P 900 $2.00 Acquired 445552 Direct

Footnotes

F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.

F2: This figure includes186,773 of common stock, held by Arterio, Inc., a company owned solely by Mr. Rothschild